SCIENTURE HOLDINGS, INC. Cost of Revenue
SCIENTURE HOLDINGS, INC. (SCNX) reported Cost of Revenue of $7.86 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $7.86K.
- SCIENTURE HOLDINGS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $2.48K, a 74.18% decline year-over-year.
- SCIENTURE HOLDINGS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $75.11K, a 49.45% increase year-over-year.
- SCIENTURE HOLDINGS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $15.43K, a 74.70% decline year-over-year.
- SCIENTURE HOLDINGS, INC. cost of goods and services sold for fiscal 2025 was $100.13K, a 23.36% decline from fiscal 2024.
- SCIENTURE HOLDINGS, INC. cost of goods and services sold for fiscal 2024 was $130.64K, a 90.06% decline from fiscal 2023.
- SCIENTURE HOLDINGS, INC. cost of goods and services sold for fiscal 2023 was $1.31M, a 72.21% decline from fiscal 2022.
- SCIENTURE HOLDINGS, INC. cost of goods and services sold for fiscal 2022 was $4.73M, a 8.02% decline from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.86K 10-Q · filed 2026-08-13 | $10.34K 10-Q · filed 2026-08-13 | $85.45K derived: sum of 3 quarters · filed 2026-08-13 | $100.88K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $2.48K 10-Q · filed 2026-05-15 | $77.59K derived: sum of 2 quarters · filed 2026-05-15 | $93.02K derived: sum of 3 quarters · filed 2026-05-15 | $93.02K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $75.11K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $90.54K derived: sum of 2 quarters · filed 2026-03-30 | $90.54K derived: sum of 3 quarters · filed 2026-08-13 | $100.13K 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $15.43K 10-Q · filed 2025-11-12 | $15.43K derived: sum of 2 quarters · filed 2026-08-13 | $25.01K 10-Q · filed 2025-11-12 | $75.27K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $9.59K 10-Q · filed 2026-08-13 | $59.84K derived: sum of 3 quarters · filed 2026-08-13 | $120.82K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $9.59K 10-Q · filed 2026-05-15 | $59.84K derived: sum of 2 quarters · filed 2026-05-15 | $120.82K derived: sum of 3 quarters · filed 2026-05-15 | $140.22K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $50.26K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $111.24K derived: sum of 2 quarters · filed 2026-03-30 | $130.64K derived: sum of 3 quarters · filed 2026-03-30 | $130.64K 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $60.98K 10-Q · filed 2025-11-12 | $80.38K derived: sum of 2 quarters · filed 2025-11-12 | $80.38K 10-Q · filed 2025-11-12 | |||||
| 2024-06-30 | $19.40K 10-Q · filed 2025-08-12 | $19.40K 10-Q · filed 2025-08-12 | ||||||
| 2023-12-31 | $242.62K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $595.32K derived: sum of 2 quarters · filed 2025-03-26 | $894.70K derived: sum of 3 quarters · filed 2025-03-26 | $1.31M 10-K · filed 2025-03-26 | $5.67M 10-K · filed 2024-04-22 | |||
| 2023-09-30 | $352.69K 10-Q · filed 2024-11-06 | $353.45K 10-Q · filed 2024-01-16 | $652.08K derived: sum of 2 quarters · filed 2024-11-06 | $1.07M 10-Q · filed 2024-11-06 | $1.07M 10-Q · filed 2024-01-16 | $1.81M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $299.39K 10-Q · filed 2024-08-09 | $606.35K 10-Q · filed 2023-08-18 | $719.48K 10-Q · filed 2024-08-09 | $1.30M 10-Q · filed 2023-08-18 | $1.46M derived: sum of 3 quarters · filed 2024-08-09 | $2.14M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $420.10K 10-Q · filed 2024-06-26 | $690.67K 10-Q · filed 2023-05-15 | $1.16M derived: sum of 2 quarters · filed 2024-06-26 | $1.84M derived: sum of 3 quarters · filed 2024-06-26 | $3.95M derived: sum of 4 quarters · filed 2024-06-26 | |||
| 2022-12-31 | $739.66K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | $1.42M derived: sum of 2 quarters · filed 2024-04-22 | $3.53M derived: sum of 3 quarters · filed 2024-04-22 | $4.73M 10-K · filed 2024-04-22 | $6.00M 10-K · filed 2023-03-27 | |||
| 2022-09-30 | $683.38K 10-Q · filed 2024-01-16 | $998.32K 10-Q · filed 2022-11-07 | $2.79M derived: sum of 2 quarters · filed 2024-01-16 | $3.99M 10-Q · filed 2024-01-16 | $5.01M 10-Q · filed 2022-11-07 | $5.84M derived: sum of 4 quarters · filed 2024-01-16 | ||
| 2022-06-30 | $2.11M 10-Q · filed 2023-08-18 | $4.01M 10-Q · filed 2023-08-18 | $5.16M derived: sum of 3 quarters · filed 2023-08-18 | $6.43M derived: sum of 4 quarters · filed 2023-08-18 | ||||
| 2022-03-31 | $1.90M 10-Q · filed 2023-05-15 | $3.05M derived: sum of 2 quarters · filed 2023-05-15 | $4.32M derived: sum of 3 quarters · filed 2023-05-15 | $5.38M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $2.42M derived: sum of 2 quarters · filed 2023-03-27 | $3.47M derived: sum of 3 quarters · filed 2023-03-27 | $5.14M 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | $1.27M 10-Q · filed 2022-11-07 | $2.33M derived: sum of 2 quarters · filed 2022-11-07 | $4.00M 10-Q · filed 2022-11-07 | $5.86M derived: sum of 4 quarters · filed 2022-11-07 | ||||
| 2021-06-30 | $1.06M 10-Q · filed 2022-07-25 | $2.73M 10-Q · filed 2022-07-25 | $4.59M derived: sum of 3 quarters · filed 2022-07-25 | $8.99M derived: sum of 4 quarters · filed 2022-07-25 | ||||
| 2021-03-31 | $1.67M 10-Q · filed 2022-05-09 | $3.53M derived: sum of 2 quarters · filed 2022-05-09 | $7.93M derived: sum of 3 quarters · filed 2022-05-09 | $12.52M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $6.26M derived: sum of 2 quarters · filed 2022-03-28 | $10.85M derived: sum of 3 quarters · filed 2022-03-28 | $11.42M 10-K · filed 2022-03-28 | ||||
| 2020-09-30 | $4.40M 10-Q · filed 2021-10-25 | $8.99M derived: sum of 2 quarters · filed 2021-10-25 | $9.55M 10-Q · filed 2021-10-25 | $10.00M derived: sum of 4 quarters · filed 2021-10-25 | ||||
| 2020-06-30 | $4.59M 10-Q · filed 2021-07-26 | $5.15M 10-Q · filed 2021-07-26 | $5.60M derived: sum of 3 quarters · filed 2021-07-26 | $6.60M derived: sum of 4 quarters · filed 2021-07-26 | ||||
| 2020-03-31 | $563.18K 10-Q · filed 2021-04-26 | $1.01M derived: sum of 2 quarters · filed 2021-04-26 | $2.01M derived: sum of 3 quarters · filed 2021-04-26 | $2.76M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-12-31 | $445.61K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $1.45M derived: sum of 2 quarters · filed 2021-03-29 | $2.20M derived: sum of 3 quarters · filed 2021-03-29 | $2.57M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $1.00M 10-Q · filed 2020-10-26 | $1.75M derived: sum of 2 quarters · filed 2020-10-26 | $2.12M 10-Q · filed 2020-10-26 | $2.57M derived: sum of 4 quarters · filed 2020-10-26 | ||||
| 2019-06-30 | $753.14K 10-Q · filed 2020-07-27 | $1.12M 10-Q · filed 2020-07-27 | $1.57M derived: sum of 3 quarters · filed 2020-07-27 | $1.57M derived: sum of 4 quarters · filed 2020-07-27 | ||||
| 2019-03-31 | $365.84K 10-Q · filed 2020-05-04 | $812.54K derived: sum of 2 quarters · filed 2020-05-04 | $814.89K derived: sum of 3 quarters · filed 2020-05-04 | |||||
| 2018-12-31 | $446.70K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $449.05K derived: sum of 2 quarters · filed 2020-03-30 | $449.05K 10-K · filed 2020-03-30 | |||||
| 2018-09-30 | $2.35K 10-Q · filed 2019-10-28 | $2.35K 10-Q · filed 2019-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |